Awarded
BEVACIZUMABUM-biosimilar conc pt sol perf 25mg/ml -fl 100 mg
Original language: Romanian
- Contract value
- RON 622,209
- Bids received
- 6
- Published
- 22 Oct 2026
- Awarded
- 14 Oct 2025
- Contract start
- 14 Oct 2025
- Contract end
- 27 Oct 2026estimated
More awards from this buyer
| Awarded | Buyer | Winner | Contract value | Published |
|---|
| Default lot | SPITALUL CLINIC MUNICIPAL CLUJ-NAPOCA | ALLIANCE HEALTHCARE ROMÂNIA SRL, DR.MAX | RON 34,262,893 | 26 Oct 2026 |
| CALCII FOLINAS sol inj/perf 10 mg/ml-flacon 10 ml | SPITALUL CLINIC MUNICIPAL CLUJ-NAPOCA | COMPANIA NATIONALA UNIFARM, DR.MAX, FARMEXIM S.A. | RON 502,240 | 23 Oct 2026 |
| AVELUMABUM CONC. PT. SOL. PERF 20mg/ml-10 ml (200mg) | SPITALUL CLINIC MUNICIPAL CLUJ-NAPOCA | DR.MAX, FARMEXIM S.A., MERCK ROMANIA S.R.L. | RON 33,073,335 | 23 Oct 2026 |
| PEMBROLIZUMABUM conc.pt.sol.perf 25mg/ml-4ml (100mg) | SPITALUL CLINIC MUNICIPAL CLUJ-NAPOCA | ALLIANCE HEALTHCARE ROMÂNIA SRL, DR.MAX, FARMEXIM S.A. | RON 145,772,611 | 23 Oct 2026 |
| DURVALUMABUM conc pt sol perf 50 mg/ml fl a 10 ml (500 mg) | SPITALUL CLINIC MUNICIPAL CLUJ-NAPOCA | ALLIANCE HEALTHCARE ROMÂNIA SRL, DR.MAX, FARMEXIM S.A. | RON 31,570,461 | 23 Oct 2026 |
| DOXORUBICINUM( lipozomală polietilenglicată) 2 mg/ml conc. pt. sol. perf.-fl 10ml | SPITALUL CLINIC MUNICIPAL CLUJ-NAPOCA | ALLIANCE HEALTHCARE ROMÂNIA SRL, DR.MAX, FARMEXIM S.A. | RON 175,799 | 23 Oct 2026 |